MIRABELLA FINANCIAL SERVICES LLP
Position in DSGN — Design Therapeutics, Inc.
CIK 1538853
London, X0
Position in DSGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$125,700
New position
Shares Held
11,814
first reported quarter
Ownership
0.019%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026MIRABELLA FINANCIAL SERVICES LLP holds $8,690,870 across 20 Biotechnology names. DSGN ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HRMY |
Harmony Biosciences Holdings, Inc.
|
115,934 | $3,247,311 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
294,628 | $2,495,499 | |
| 3 | ABVX |
Abivax S.A.
|
4,256 | $473,905 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
10,188 | $410,678 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,557 | $294,350 | |
| 6 | NAGE |
Niagen Bioscience, Inc.
|
43,074 | $189,956 | |
| 7 | ANNX |
Annexon, Inc.
|
28,739 | $159,214 | |
| 8 | ADMA |
Adma Biologics, Inc.
|
17,644 | $158,972 |
All Filings in DSGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $125,700 | 11,814 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||